These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 34018627

  • 1. Combination of Model for End-Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding.
    Walter A, Rudler M, Olivas P, Moga L, Trépo E, Robic MA, Ollivier-Hourmand I, Baiges A, Sutter O, Bouzbib C, Peron JM, Le Pennec V, Ganne-Carrié N, Garcia-Pagán JC, Mallet M, Larrue H, Dao T, Thabut D, Hernández-Gea V, Nault JC, Bureau C, Allaire M, Salvage TIPS Group.
    Hepatology; 2021 Oct; 74(4):2085-2101. PubMed ID: 34018627
    [Abstract] [Full Text] [Related]

  • 2. Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Maimone S, Saffioti F, Filomia R, Alibrandi A, Isgrò G, Calvaruso V, Xirouchakis E, Guerrini GP, Burroughs AK, Tsochatzis E, Patch D.
    Dig Dis Sci; 2019 May; 64(5):1335-1345. PubMed ID: 30560334
    [Abstract] [Full Text] [Related]

  • 3. Transjugular Intrahepatic Porto-Systemic Shunt in Patients with Liver Cirrhosis and Model for End-Stage Liver Disease ≥15.
    Ascha M, Hanouneh M, S Ascha M, Zein NN, Sands M, Lopez R, Hanouneh IA.
    Dig Dis Sci; 2017 Feb; 62(2):534-542. PubMed ID: 27154510
    [Abstract] [Full Text] [Related]

  • 4. Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question.
    Pitton MB, Zimmermann T, Mildenberger P, Weinmann A, Kloeckner R, Düber C, Mittler J, Hoppe-Lotichius M, Otto G.
    Eur J Gastroenterol Hepatol; 2021 Dec 01; 33(1S Suppl 1):e214-e222. PubMed ID: 33230020
    [Abstract] [Full Text] [Related]

  • 5. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
    Tejedor-Tejada J, Fuentes-Valenzuela E, García-Pajares F, Nájera-Muñoz R, Almohalla-Álvarez C, Sánchez-Martín F, Calero-Aguilar H, Villacastín-Ruiz E, Pintado-Garrido R, Sánchez-Antolín G.
    Gastroenterol Hepatol; 2021 Nov 01; 44(9):620-627. PubMed ID: 33249114
    [Abstract] [Full Text] [Related]

  • 6. Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: A systematic review with meta-analysis.
    Weichselbaum L, Lepida A, Marot A, Trépo E, Moreno C, Deltenre P.
    United European Gastroenterol J; 2022 Oct 01; 10(8):874-887. PubMed ID: 36217553
    [Abstract] [Full Text] [Related]

  • 7. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
    Bai M, He CY, Qi XS, Yin ZX, Wang JH, Guo WG, Niu J, Xia JL, Zhang ZL, Larson AC, Wu KC, Fan DM, Han GH.
    World J Gastroenterol; 2014 Jan 21; 20(3):774-85. PubMed ID: 24574750
    [Abstract] [Full Text] [Related]

  • 8. Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage.
    Hermie L, Dhondt E, Vanlangenhove P, Hoste E, Geerts A, Defreyne L.
    Eur J Gastroenterol Hepatol; 2018 Dec 21; 30(12):1441-1446. PubMed ID: 30048333
    [Abstract] [Full Text] [Related]

  • 9. Prediction of mortality after emergent transjugular intrahepatic portosystemic shunt placement: use of APACHE II, Child-Pugh and MELD scores in Asian patients with refractory variceal hemorrhage.
    Tzeng WS, Wu RH, Lin CY, Chen JJ, Sheu MJ, Koay LB, Lee C.
    Korean J Radiol; 2009 Dec 21; 10(5):481-9. PubMed ID: 19721833
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of clinical outcome and predictors of mortality in patients undergoing antegrade transvenous variceal embolization in adjunct to salvage transjugular intrahepatic portosystemic shunt for active uncontrolled gastric variceal bleeding.
    Patidar Y, Chatterjee N, Mukund A, Sarin SK.
    Br J Radiol; 2024 Nov 01; 97(1163):1791-1798. PubMed ID: 39120077
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention.
    Krige JEJ, Jonas EG, Setshedi M, Beningfield SJ, Lotze UK, Bernon MM, Burmeister S, Kloppers JC.
    S Afr Med J; 2023 Dec 31; 114(1):39-43. PubMed ID: 38525611
    [Abstract] [Full Text] [Related]

  • 12. Right atrial pressure may impact early survival of patients undergoing transjugular intrahepatic portosystemic shunt creation.
    Parvinian A, Bui JT, Knuttinen MG, Minocha J, Gaba RC.
    Ann Hepatol; 2014 Dec 31; 13(4):411-9. PubMed ID: 24927612
    [Abstract] [Full Text] [Related]

  • 13. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S.
    World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012
    [Abstract] [Full Text] [Related]

  • 14. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Dec 07; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 15. Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival.
    Bettinger D, Sturm L, Pfaff L, Hahn F, Kloeckner R, Volkwein L, Praktiknjo M, Lv Y, Han G, Huber JP, Boettler T, Reincke M, Klinger C, Caca K, Heinzow H, Seifert LL, Weiss KH, Rupp C, Piecha F, Kluwe J, Zipprich A, Luxenburger H, Neumann-Haefelin C, Schmidt A, Jansen C, Meyer C, Uschner FE, Brol MJ, Trebicka J, Rössle M, Thimme R, Schultheiss M.
    J Hepatol; 2021 Jun 07; 74(6):1362-1372. PubMed ID: 33508376
    [Abstract] [Full Text] [Related]

  • 16. Long-term effects and complications of the transjugular intrahepatic portosystemic shunt: a single-centre experience.
    Kraglund F, Jepsen P, Amanavicius N, Aagaard NK.
    Scand J Gastroenterol; 2019 Jul 07; 54(7):899-904. PubMed ID: 31203699
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
    Lerrigo R, Beste LA, Leipertz SL, Green PK, Lok AS, Kogut MJ, Ioannou GN.
    Eur J Gastroenterol Hepatol; 2016 Jun 07; 28(6):667-75. PubMed ID: 26886386
    [Abstract] [Full Text] [Related]

  • 19. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT, Yang AH, Urban S, Kim KY, Ter-Oganesyan R, Yuan L, Han HH, Khemichian S, Kahn JA, Kim B.
    Eur J Gastroenterol Hepatol; 2021 Apr 01; 33(4):541-546. PubMed ID: 32398491
    [Abstract] [Full Text] [Related]

  • 20. Rapid change of liver stiffness after variceal ligation and TIPS implantation.
    Piecha F, Paech D, Sollors J, Seitz HK, Rössle M, Rausch V, Mueller S.
    Am J Physiol Gastrointest Liver Physiol; 2018 Feb 01; 314(2):G179-G187. PubMed ID: 29051188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.